[
  {
    "batch_index": 0,
    "model": "gpt-5-mini",
    "response_id": "resp_03f7e18bb213ba9c00690bd2c208ac8196aeecbe915d330ee6",
    "usage": {
      "prompt_tokens": 1750,
      "completion_tokens": 1533,
      "total_tokens": 3283
    },
    "content": "{\n  \"condition\": \"Duchenne muscular dystrophy\",\n  \"drugs\": [\n    {\n      \"id\": \"drug:succinylcholine\",\n      \"name\": \"succinylcholine\",\n      \"classifications\": [],\n      \"atc_codes\": [],\n      \"claims\": [\n        \"claim:malignant-hyperthermia-like-succinylcholine\"\n      ]\n    }\n  ],\n  \"claims\": [\n    {\n      \"id\": \"claim:malignant-hyperthermia-like-succinylcholine\",\n      \"type\": \"risk\",\n      \"summary\": \"Case reports describe malignant hyperthermia-like reactions in patients with Duchenne muscular dystrophy who received succinylcholine during anesthesia, indicating an elevated perioperative risk associated with succinylcholine in this population.\",\n      \"confidence\": \"low\",\n      \"idiosyncratic_reaction\": {\n        \"flag\": true,\n        \"descriptors\": [\n          \"malignant hyperthermia-like reaction\"\n        ]\n      },\n      \"articles\": [\n        \"article:11111111\"\n      ],\n      \"drugs\": [\n        \"drug:succinylcholine\"\n      ],\n      \"drug_classes\": [],\n      \"supporting_evidence\": [\n        {\n          \"snippet_id\": \"snippet:1\",\n          \"pmid\": \"11111111\",\n          \"article_title\": \"Safety considerations for neuromuscular blockade in dystrophinopathies\",\n          \"key_points\": [\n            \"Case reports highlight malignant hyperthermia-like reactions when patients with Duchenne muscular dystrophy receive succinylcholine during anesthesia.\",\n            \"These reports suggest an elevated perioperative risk associated with succinylcholine in dystrophinopathies.\"\n          ],\n          \"notes\": \"\"\n        }\n      ]\n    }\n  ]\n}",
    "parsed": {
      "condition": "Duchenne muscular dystrophy",
      "drugs": [
        {
          "id": "drug:succinylcholine",
          "name": "succinylcholine",
          "classifications": [],
          "atc_codes": [],
          "claims": [
            "claim:malignant-hyperthermia-like-succinylcholine"
          ]
        }
      ],
      "claims": [
        {
          "id": "claim:malignant-hyperthermia-like-succinylcholine",
          "type": "risk",
          "summary": "Case reports describe malignant hyperthermia-like reactions in patients with Duchenne muscular dystrophy who received succinylcholine during anesthesia, indicating an elevated perioperative risk associated with succinylcholine in this population.",
          "confidence": "low",
          "idiosyncratic_reaction": {
            "flag": true,
            "descriptors": [
              "malignant hyperthermia-like reaction"
            ]
          },
          "articles": [
            "article:11111111"
          ],
          "drugs": [
            "drug:succinylcholine"
          ],
          "drug_classes": [],
          "supporting_evidence": [
            {
              "snippet_id": "snippet:1",
              "pmid": "11111111",
              "article_title": "Safety considerations for neuromuscular blockade in dystrophinopathies",
              "key_points": [
                "Case reports highlight malignant hyperthermia-like reactions when patients with Duchenne muscular dystrophy receive succinylcholine during anesthesia.",
                "These reports suggest an elevated perioperative risk associated with succinylcholine in dystrophinopathies."
              ],
              "notes": ""
            }
          ]
        }
      ]
    }
  }
]